Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

Genomic Health Inc

+ Add to Watchlist

GHDX:US

37.2500 USD 0.7000 1.92%

As of 20:10:00 ET on 05/17/2013.

Company Profile for Genomic Health Inc (GHDX)

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer. The Company's diagnostic services provide information on the likelihood of disease recurrence and response to certain types of therapy.

Contact Information

Genomic Health Inc

301 Penobscot Drive
Redwood City, CA 94063
United States
Phone: 1-650-556-9300

Key Executives for Genomic Health Inc (GHDX)

Kimberly J Popovits "Kim"Chairman/President/CEODean L SchornoChief Financial Officer
G Bradley ColeChief Operating OfficerSteven ShakExec VP:Research & Dev
Kathy L HibbsSenior VP/Secy/General Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil